Oruka Therapeutics (ORKA) Current Assets (2010 - 2026)

Oruka Therapeutics has reported Current Assets for 17 years, with the latest figure at $395.2 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 12.26% year-over-year to $395.2 million; the trailing twelve-month figure through Mar 2026 stood at $395.2 million (up 12.26% YoY), and the FY2025 full-year result was $343.9 million, down 8.76% from the prior year.
• Current Assets for Q1 2026 stood at $395.2 million, up from $343.9 million in the prior quarter.
• The five-year high for Current Assets was $412.9 million in Q3 2024, with the low at $33.8 million in Q2 2024.
• Average Current Assets over 5 years is $175.5 million, with a median of $47.7 million recorded in 2022.
• Year-over-year, Current Assets fell 26.47% in 2022 and soared 961.78% in 2024.
• Tracing ORKA's Current Assets over 5 years: stood at $42.7 million in 2022, then dropped by 11.96% to $37.6 million in 2023, then jumped by 902.52% to $376.9 million in 2024, then dropped by 8.76% to $343.9 million in 2025, then grew by 14.95% to $395.2 million in 2026.
• The last three Current Assets figures came in at $395.2 million (Q1 2026), $343.9 million (Q4 2025), and $355.2 million (Q3 2025), per Business Quant data.

Peer Comparison